- Ironwood Pharmaceuticals ( NASDAQ: IRWD ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.
- The consensus EPS Estimate is $0.30 (-11.8% Y/Y) and the consensus Revenue Estimate is $103.51M (-0.5% Y/Y).
- Over the last 2 years, IRWD has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 3 downward. Revenue estimates have seen 1 upward revision and 2 downward.
For further details see:
Ironwood Pharmaceuticals Q2 2022 Earnings Preview